STAT

Opinion: Lab animal regulations can be simplified without weakening welfare standards

In this era of enthusiasm for deregulation, federal decision-makers must remember the important role that oversight plays in ensuring the humane care and use of lab animals.
Source: Sherman/Getty Images

The National Institutes of Health recently began seeking public input on revising laboratory animal research policies and regulations, a review mandated by the 21st Century Cures Act.

In coordination with the Food and Drug Administration and the Department of Agriculture, the agency is looking for ways to reduce the administrative burden researchers face, while protecting lab animals and maintaining the integrity of research results.

Public Responsibility in Medicine and Research, the nonprofit organization that I lead, along with other biomedical research stakeholders, agree that review and reform of federal policies for

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About MorphoSys Drug Risks, An AstraZeneca Admission, And More
MorphoSys is dealing with a safety issue with pelabresib, the experimental treatment for myelofibrosis and centerpiece of its proposed $3 billion acquisition by Novartis.
STAT2 min readCrime & Violence
STAT+: Pharmalittle: We’re Reading About A Medicare Price-negotiation Ruling, Pharma’s Slipping Reputation, And More
A U.S. judge dealt a blow to two drugmakers challenging the authority for Medicare to negotiate the prices of prescription drugs.
STAT2 min readAmerican Government
STAT+: Pharmalittle: We’re Reading About FTC Reviewing Novo-Catalent Deal, Amneal Opioid Settlement, And More
The FTC wants more information on a $16.5 million deal in which Novo Nordisk's parent company would purchase Catalent, a contract drug manufacturer.

Related